Northrop Grumman's Q1 2025 results showed a revenue decline and significantly lower EPS due to a one-time B-21 adjustment. However, the company maintains a record backlog and reaffirmed full-year sales guidance, highlighting strong demand in defense.
Revenue declined 7% YoY due to fewer working days and space program wind-down.
EPS dropped to $3.32 due to a $2.74 impact from the B-21 production ramp adjustment.
Backlog reached a record $92.8 billion, supporting future growth visibility.
Adjusted EPS estimated at $6.06 when excluding the B-21 impact.
Northrop Grumman reaffirmed its sales expectations across segments but lowered full-year operating income and EPS guidance due to B-21 program cost increases.
Visualization of income flow from segment revenue to net income